Portosystemic Shunt in Pediatric Living Donor Liver Transplant

Transplant Proc. 2022 Mar;54(2):403-405. doi: 10.1016/j.transproceed.2021.09.072. Epub 2022 Jan 10.

Abstract

Background: To evaluate the significance of portosystemic shunts and associated long-term outcomes in living donor liver transplant (LDLT) among pediatric patients.

Methods: Retrospective review of 121 pediatric patients who underwent LDLT between May 1994 and December 2015 at Taiwan Kaohsiung Chang Gung Memorial Hospital. Pre- and postoperative computed tomography images of the liver were reviewed, and portal vein complications were assessed.

Results: Ninety-seven pediatric patients were included in the study, and 70 had portosystemic shunts before transplant. Thirty-three patients have portal systemic shunt (PSS) 6 months after transplant (mean [SD] shunt size, 4.59 [1.98] mm). Thirty-seven patients' portosystemic shunts closed spontaneously (mean [SD] shunt size, 3.14 [1.06] mm). Smaller PSSs tend to close spontaneously with a cutoff point of 3.35 mm by receiver operating characteristic curve (P = .01). Patients with PSS have more portal vein complications than those without PSS (44.3% vs 11.1%, P = .02). Among PSS recipients, patients with portal vein complications tend to have larger PSS size (mean [SD], 4.14 [1.96] mm vs 3.59 [1.48] mm), although the difference is not statistically significant (P = .19).

Conclusions: In pediatric patients, preoperative portosystemic shunts are significantly correlated with portal venous complications, some of which require minimal interventions after LDLT with good outcomes. Shunts larger than 3.35 mm tend to persist after transplant with increased portal venous complications.

MeSH terms

  • Child
  • Humans
  • Liver Transplantation*
  • Living Donors
  • Portal Vein / diagnostic imaging
  • Portal Vein / surgery
  • Portasystemic Shunt, Surgical / adverse effects
  • Portasystemic Shunt, Surgical / methods
  • Portasystemic Shunt, Transjugular Intrahepatic*
  • Retrospective Studies